Expression of Ferroptosis-Related Genes is Correlated with Immune Microenvironment in Diabetic Kidney Disease
Lihua Ni,Jingyuan Cao,Cheng Yuan,Le-Ting Zhou,Xiaoyan Wu
DOI: https://doi.org/10.2147/DMSO.S388724
2022-12-28
Abstract:Lihua Ni, 1, &ast Jingyuan Cao, 2, &ast Cheng Yuan, 3 Le-Ting Zhou, 4 Xiaoyan Wu 1 1 Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China; 2 The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China; 3 Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China; 4 Department of Nephrology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaoyan Wu; Le-Ting Zhou, Email ; Objective: This study aims to explore the correlation between ferroptosis and immune microenvironment (IME) in diabetic kidney disease (DKD) to provide a new clue for exploring the underlying molecular mechanisms. Methods: Corresponding RNA data of DKD patients were downloaded from GEO databases. The weighted gene co-expression network analysis (WGCNA) was used to construct the network, and the selected hub genes, then, overlapped with ferroptosis-related genes (FRGs) from FerrDb. Consensus clustering was performed to identify new molecular subgroups. ESTIMATE, TIMER and ssGSEA analyses were applied to determinate the IME and immune status. Functional analyses including GO, KEGG and GSEA were conducted to elucidate the underlying mechanisms. Results: Two molecular subtypes were identified based on the expression of FRGs. ESTIMATE algorithm revealed that there were significant differences in ESTIMATE score between these two clusters of DKD patients, with no significant difference found in stromal score and immune score. In addition, TIMER algorithm indicated there was a significant difference in the degree of T cell infiltration. The ssGSEA algorithm showed immunity was mainly concentrated in thick ascending limb and distal convoluted tubule in adult kidney. GO, KEGG and GSEA analyses revealed that the differentially expressed genes (DEGs) were mainly enriched in immune and metabolism associated pathways. Conclusion: The ferroptosis may be induced by dysregulation of IME, thereby accelerating the progression of DKD. Our work could be applied to provide a new clue for exploring the underlying molecular mechanisms and sheds novel light on the therapy strategy of DKD. Keywords: diabetic kidney disease, DKD, ferroptosis, immune microenvironment, IME, metabolism With the continuous growth of the elderly population, the incidence of chronic diseases such as diabetes is increasing year by year, which is a major challenge facing the public medical system. 1,2 Diabetes is a disease with a longer course. If not treated in time, the development of the disease will lead to microvascular lesions and other complications. 3 Among them, diabetic kidney disease (DKD) is a high-risk complication caused by progressive diabetes, which leads to a continuous decline in the patient's renal function and seriously affects the patient's health and even endangers the patient's life. 4,5 DKD develops in about 40% of the patients with diabetic and is the first cause of most end-stage renal disease among the world. 6 The pathogenesis of DKD is complex and multifactorial with the participation of many pathways and mediators, such as hemodynamic abnormalities, metabolic disorders, hormone synthesis, reactive oxygen species (ROS), protein kinase (PKC), mitogen-activated protein kinase (MAPKs) and so on. Each pathway causes damage via multiple regulators or interacts with other pathways. The exact pathogenic mechanism and molecular incidence of DN are still largely uncertain. Ferroptosis is considered as cell death dependent on intracellular iron, which is characterized by the increase of ROS to lethal levels. 7 Although the interaction between ferroptosis and acute kidney injury (AKI) had been continuously explored, studies on ferroptosis and chronic renal disease remain lacking. Due to the sensitivity of renal tubules to ROS, ferroptosis also occurs in the development of DKD by increasing oxidative stress and reducing antioxidant capacity. 8–10 Therefore, ferroptosis may provide a new explanation for the pathogenesis of DKD. Li et al 9 demonstrated that up-regulating NFE2-related factor 2 (NRF2) by treating with fenofibrate inhibited diabetes-related ferroptosis, which consequently delayed progression of DKD. Feng et al 10 indicated that ferroptosis might enhance DN and damage renal tubules in diabetic models through HIF-1α/HO-1 pathway. Considering the -Abstract Truncated-